Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Feb 1;37(2):343-9.
doi: 10.5665/sleep.3410.

National use of prescription medications for insomnia: NHANES 1999-2010

Affiliations

National use of prescription medications for insomnia: NHANES 1999-2010

Suzanne M Bertisch et al. Sleep. .

Abstract

Study objectives: To determine current patterns and predictors of use of prescription medications commonly used for insomnia (MCUFI) in the U.S.

Design: Cross-sectional study.

Setting: National Health and Nutrition Examination Survey, 1999-2010.

Participants: 32,328 noninstitutionalized community-dwelling U.S. adults.

Interventions: N/A.

Measurements and results: WE DEFINED MCUFI USE AS USE OF ANY OF THE FOLLOWING MEDICATIONS IN THE PRECEDING MONTH: benzodiazepine receptor agonists (eszopiclone, zaleplon, zolpidem, estazolam, flurazepam, quazepam, temazepam, triazolam), barbiturates (amobarbital, amobarbitalsecobarbital, chloral hydrate), doxepin, quetiapine, ramelteon, and trazodone. We estimated prevalence of MCUFI use and concurrent use of another sedating medication. We determined predictors of MCUFI use using multivariate logistic regression. Overall, 3% percent of adults used a MCUFI within the preceding month. Zolpidem and trazodone were used most commonly. Overall MCUFI use increased between 1999-2000 and 2009-2010 (P value for trend < 0.001). Concurrent use of other sedating medications was high, with 55% of MCUFI users taking at least one other sedating medication and 10% taking ≥ 3 other sedating medications. Concurrent use of MCUFIs with opioids (24.6%) and non-MCUFI benzodiazepines (19.5%) were most common. After adjustment, adults seeing a mental health provider (aOR 4.68, 95% C.I. 3.79, 5.77), using other sedating medications (aOR 4.18, 95% C.I. 3.36, 5.19), and age ≥ 80 years (aOR 2.55, 95% C.I. 1.63, 4.01) had highest likelihood of MCUFI use.

Conclusion: In this nationally representative sample, reported use of prescription medications commonly used for insomnia (MCUFIs) within the preceding month was common, particularly among older adults and those seeing a mental health provider, with high use of sedative polypharmacy among MCUFI users.

Keywords: Insomnia; NHANES; benzodiazepines; hypnotics and sedatives; prescription medication use; sleep disorders.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Prescription medication commonly used for insomnia (MCUFI), past month: 1999-2010. *Unreliable estimate (n < 30). **P value for trend < 0.001. Z-meds: eszopiclone, zaleplon, zolpidem.

References

    1. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6:97–111. - PubMed
    1. Moloney ME, Konrad TR, Zimmer CR. The medicalization of sleeplessness: a public health concern. Am J Public Health. 2011;101:1429–33. - PMC - PubMed
    1. Buscemi N, Vandermeer B, Friesen C, et al. The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med. 2007;22:1335–50. - PMC - PubMed
    1. Verster JC, Veldhuijzen DS, Patat A, Olivier B, Volkerts ER. Hypnotics and driving safety: meta-analyses of randomized controlled trials applying the on-the-road driving test. Curr Drug Saf. 2006;1:63–71. - PubMed
    1. Fick D, S T, Beizer J, Brandt N, et al. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60:616–31. - PMC - PubMed

Publication types

Substances